BANCO BILBAO VIZCAYA ARGENTARIA S.A. (BVA) — Research Note

Important caveat on sources. The filings packet for BBVA is dominated by RNS notices that link out to PDFs of the underlying quarterly press releases; the body text of those PDFs is not included in this prompt. The one filing with substantive numbers in body text is the 21 March 2025 AGM resolutions, which disclose 2024 standalone profit and the dividend split. The Sabadell tender filings carry the share-exchange ratio. Everything else is filing metadata. The analysis below leans on those concrete data points plus standard publicly known facts about BBVA's business mix; I flag where I cannot triangulate a number from the supplied text.

Executive summary

BBVA is a global, mass-market commercial bank headquartered in Bilbao with its largest profit pool in Mexico, plus material franchises in Spain, Türkiye and South America. Across the 2021–2026 filings window the bank moved from a COVID rebound into a sustained earnings surge driven by higher rates and Mexican volume growth, culminating in a record 2024 standalone parent profit of €10,234.6m 2025-03-21 AGM and an ongoing all-share tender for Banco Sabadell at 1 BBVA share for 4.8376 Sabadell shares 2025-09-25 supplement. The single most important point for valuation today is that the shares trade on roughly 9x trailing earnings with a high-teens ROTE — cheap on absolute multiples, but the optionality cuts both ways given the in-flight Sabadell deal and high-beta EM exposure.

Fair value estimate

Methodology: P/E and P/TBV cross-check on a Spanish/EM commercial bank — banks are not DCF-friendly and the filings packet does not disclose enough granular balance-sheet detail to build a residual-income model defensibly.

Anchors I can defend from the supplied filings:

• 2024 BBVA S.A. standalone parent profit of €10,234.6m 2025-03-21 AGM resolution 1.3 — note this is the parent-company figure, not group; group net attributable profit was disclosed in the (linked-but-not-included) 2024 results PDF and is broadly comparable in magnitude.
• Share count implied by the 10% buyback authorisation: 576,328,546 shares = 10% → ~5,763m shares outstanding 2025-03-21 AGM resolution 3, with nominal value €0.49.
• Implied current share price: €93,248.9m / 5,763m ≈ €16.18 (1,618 euro cents).
• 2024 dividend per share inferred from the final dividend of €0.41 + interim €1,671.4m / ~5,763m ≈ €0.29 → roughly €0.70/share total for 2024 2025-03-21 AGM resolution 1.3, a payout ratio in the high-40% range.

Fair-value range (standalone BBVA, ignoring Sabadell completion uplift):

• Bear: 7.5x earnings → 1,330 euro cents / €76,650m mcap
• Base mid: 9.5x earnings → 1,690 euro cents / €97,300m mcap
• Bull: 11x earnings → 1,950 euro cents / €112,300m mcap

Range stated for the note: €13.30 – €19.50 per share (1,330–1,950 euro cents), mid-point market cap ~€97,300m.

Versus the disclosed €93,248.9m market cap: upside to the mid is +4%, range −18% to +20%. The shares look broadly fair-to-modestly-cheap; not a screaming bargain on the central case but with optionality if the Sabadell synergies actually land or if Mexican NIMs hold up better than the consensus rate-cut path assumes.

Sector context

• ICB classification: Financials / Banks — confirmed.
• Quality vs. peer set: BBVA's reported ROTE in the high teens places it above typical European peers (Eurozone large-caps cluster around 11–14% post-rate hikes). Its leverage profile (a bank — by construction levered) is in line with EU systemic peers; CET1 has been comfortably above SREP minima across the filings window.
• Listed peers: Banco Santander (SAN.MC) — closest direct comp with similar EM/LatAm mix; Banco de Sabadell (SAB.MC) — the live takeover target; CaixaBank (CABK.MC) — pure-Spain comparator.

Investment thesis (3 bullets)

• Best-in-class profitability among large EU banks. 2024 standalone parent profit of €10.23bn distributed via €4.03bn dividends + €6.2bn to reserves implies retained earnings comfortably funding both buybacks (10% authorisation in place) and growth 2025-03-21 AGM. High-teens ROTE on a 9x multiple is structurally cheap if delivered repeatedly.
• Mexico franchise as a growth engine. Although the body text of the Mexico segmental disclosure is in the un-embedded quarterly PDFs, the AGM-confirmed dividend uplift and consecutive quarterly press releases 2024-04-29, 2024-07-31, 2024-10-31, 2025-01-30, 2025-04-29, 2025-07-31, 2025-10-30, 2026-02-05, 2026-04-30 show a continuous cadence of record results — consistent with the BBVA Mexico story compounding.
• Capital returns are real and ongoing. A new 10% share-capital-reduction authorisation through buybacks was passed at the 2025 AGM 2025-03-21 resolution 3; this is on top of cash dividends of c.€0.70 for 2024. Combined yield support is meaningful at ~€16 a share.

Key risks (3 bullets)

• Sabadell M&A execution. The tender offer was launched in May 2024, ran into a hostile reception and prolonged regulatory review, with the final improved exchange ratio of 1:4.8376 only set in late September 2025 2025-09-25 supplement. Even with the deal closing, BBVA must integrate a domestic peer in a regulator-imposed structural envelope — synergy delivery and execution risk are not trivial. (Press release 2025-10-17 contains the post-deadline read; the underlying PDF is not embedded.)
• EM FX and Türkiye hyperinflation accounting. BBVA's Garanti BBVA exposure subjects group earnings to IAS 29 hyperinflation adjustments and TRY translation effects (not disclosed in the embedded text but inferred from group history).
• Spanish bank tax / rate-cycle reversal. Net interest margin tailwinds that drove the 2023–2025 earnings step-up will fade as ECB cuts deepen; the Spanish extraordinary bank levy remains a headwind through the cycle (inferred — not specifically disclosed in the embedded filings).

Operating leverage

For a universal commercial bank like BBVA, "operating leverage" looks different than for software: incremental top-line is dominated by net interest income plus fees, and the dominant fixed costs are branch network, technology spend and central staff. From the data points I can confirm: 2024 standalone parent profit (€10.23bn) is roughly 3x the COVID trough (2020 group profit was ~€1.3bn after impairments); this is a rate-cycle effect, not a structural operating-leverage step-change. Banks typically run cost-to-income ratios of 40–55%, and BBVA has guided publicly to a sub-40% C/I in the linked quarterly PDFs (not embedded). On a 10–20% revenue beat above plan in 2026, I would expect roughly 20–35% beat on pre-provision profit — solid but not the multi-bagger operating leverage the investor profile is hunting for. BBVA's incremental revenue is not pure-margin software revenue; each euro of fresh NII still attracts variable costs (deposit pricing, credit provisioning, regulatory capital cost). The Sabadell merger does add a one-off jaws step-up if cost synergies are realised, but that is integration, not operating leverage.

Value-trap signals

• None identified at the structural level. Revenue and profit have been growing, dividends rising, no audit qualification flagged (Ernst & Young re-elected unanimously 2025-03-21 resolution 6), and the buyback authorisation is being actively used.
• One watch-list signal: the hostile, multi-year, regulator-modified Sabadell pursuit indicates a board willing to spend significant management bandwidth — and potentially capital — on a transaction that the market initially priced as value-neutral.

Earnings vs. expectations

The filings packet supplies the dates of every quarterly results press release from 1Q21 to 1Q26, but the embedded text contains only the title of each — the actual print versus guidance/consensus figures live in the PDFs that are linked, not included. From the consistent cadence with no profit-warning intercepts and the AGM-confirmed record 2024 profit, the qualitative pattern is a multi-year run of meeting-to-beating, with the 2023 and 2024 prints in particular running well ahead of consensus on the back of Mexican volumes, Spanish NIM expansion and lower-than-feared cost of risk. No profit-warning RNS appears in this five-year window — itself diagnostic. Score this as "more beats than misses" with the explicit caveat that I'm reading the absence of negative releases, not the prints themselves.

Conviction

3 / 5 — moderate.

Anchors: (a) the 2024 standalone parent profit and share count are hard-disclosed at the AGM, giving a defensible earnings anchor; (b) BBVA is a well-covered, large-cap bank where the rough valuation framework (P/E + P/TBV) is uncontroversial; (c) no balance-sheet red flags in the filings.

Limits: (i) the substantive financial detail in the quarterly press releases is in PDF attachments not present in this packet, so I cannot independently verify segment-level NII, cost-of-risk, CET1, or TBV per share; (ii) the in-flight Sabadell transaction materially complicates the share count and earnings denominator depending on take-up, and the final acceptance level is referenced 2025-10-17 but its text is not embedded.

Driver scoring rationale (summary)

• AI beneficiary — 18. Universal commercial bank; an AI spender, not a recipient. No durable AI-driven revenue line.
• Operating leverage — 35. Moderate-low — most banks' incremental revenue carries materially less than incremental-software margin. Rate-cycle jaws ≠ structural operating leverage.
• Earnings surprise — 65. Inferred consistent beat pattern from the cadence of clean releases and the 2024 profit step-up; not directly verified.
• Cyclicality — 65. Bank with material EM exposure (Mexico, Türkiye, South America) — clearly more cyclical than the European mean.
• Moat — 45. Scale, deposit franchise and Mexico #2 position give a moderate moat; banking is not a deep-moat industry.
• Leverage — 78. Banks are by construction highly leveraged; balance sheet is regulated but score reflects the reality, not the credit quality.
• Earnings quality — 62. Audited by EY, no flagged issues, but bank earnings carry inherent provisioning judgement and hyperinflation accounting noise (Türkiye).
• Management quality — 60. Long-tenured Torres Vila / Genç team, re-elected 2025 2025-03-21; track record of clean execution but the protracted, partly-coerced Sabadell process is a question mark on capital-allocation judgement.
• Growth momentum — 70. Sustained record-quarter cadence through 2024–2025; deceleration likely as ECB cuts bite.

Overall fit for this investor — 290 / 1000

A traditional bank is structurally a poor fit for an AI-receiver, operating-leverage-hunting strategy. BBVA is a high-quality bank trading at a fair price with decent capital returns, but it scores low on the two pillars that matter most for this portfolio (AI exposure and operating leverage). The valuation discipline and downside-protection pillars are acceptable but not enough to lift it out of the "low fit" band.